BECN1 and breast carcinoma: Systematic review and meta-analysis by He et al. [48] identified Beclin-1 as a favorable prognostic marker in gastric cancer, breast cancer, lung cancer, and lymphoma, whereas in colorectal cancer the results were split between favorable and poor prognostic values.